Trinity Webinar
China NRDL 2025:
Locked Out or Leveled Up?
Winning China Access in the NRDL and CIIDL Era
July 8, 2026 | 2:00 – 2:45 PM ET
Additional sessions for EU and APAC
Meet Our Trinity Experts
Pricing pressure is rising but so are new opportunities.
China’s 2025 NRDL update continues to demonstrate constrained willingness to pay while still rewarding truly differentiated therapies. Meanwhile, the emergence of a Commercial Insurance Innovative Drug List (CIIDL, formerly Category C) is creating an alternative access route for highly innovative therapies to preserve price and achieve targeted access.
This evolving dual-track access system is forcing manufacturers to rethink how and where they compete.
In this session, you will:
Understand the key takeaways from the 2025 NRDL update, including inclusion trends and pricing dynamics
Explore how oncology, rare disease, and chronic condition products performed, including analogues that achieved premium prices through clinical differentiation
Learn how China’s commercial drug list is emerging as a viable funding pathway for high-cost innovations, including cell therapies and Alzheimer’s treatment
Discuss how to strategically navigate NRDL and commercial pathways in launch and lifecycle planning
Unpack the latest NRDL negotiation outcomes and explore what the expanding CIIDL pathway means for future access strategies.
This webinar is designed for teams that own pricing, access, and launch decisions for China, including global and regional market access and pricing leaders and commercial and portfolio strategy teams focused on oncology, rare disease, and specialty therapies.
Register Now
Which session would you like to register for?
Complete the form below to register for the July 8th session at 2:00 PM ET
Complete the form below to register for the July 9th session at 12:00 UTC+8 - Asia
Complete the form below to register for the July 9th session at 12:00 CEST - Europe
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.